A jury in St. Louis found Johnson & Johnson responsible for the ovarian cancer of 22 women after a Missouri state court trial. The month long trial in St. Louis Circuit Court resulted in a $25 million per plaintiff award for damages, and an additional $4.15 billion in punitive damages against Johnson and Johnson. To… Read More
A California bill introduced by Assembly Member Quirk in 2016 to promote electric cars, AB-33, has been modified to create and sell new bonds. The proceeds of the bonds would go toward covering Pacific Gas & Electric’s legal liability after being found responsible for starting the October 2017 Northern California wildfires. Wildfire lawsuit settlements could add… Read More
An article in Chemist World titled “J&J and the question of shadow research” discusses how we should evaluate the ethics of Johnson and Johnson (J&J) hiding payment for talcum powder ovarian cancer research. Baby Powder Cancer Trial Deposition We now know that J&J paid for baby powder cancer research from cross-examination during an ovarian cancer… Read More
The future of consumers’ right to bring state law claims against pharmaceutical companies for injuries caused by their drugs hangs in the balance as the United States Supreme Court reviews the federal appellate court’s decision in Levine v. Wyeth. Hundreds of women had filed lawsuits against pharmaceutical giant, Merck, for bone fractures suffered after taking osteoporosis drug,… Read More
June 29th, 2018: A new study published June 2018 in the Lancet’s Respiratory Medicine journal found a new combination therapy that improved patient outcome compared to standard chemotherapy treatment. Combination Treatment for Mesothelioma The study paired durvalumab (Imfinzi) and tremelimumab in combination, and compared the results to standard modern chemotherapy treatment for mesothelioma. The median… Read More